inSoma Bio - About the company
inSoma Bio is a seed company based in Durham (United States), founded in 2018 by Ashutosh Chilkoti, Stefan Roberts and Scott Hollenbeck. It operates as a Provider of protein-based biomaterials for tissue engineering and regenerative medicine. inSoma Bio has raised $4.77M in funding from Y Combinator. The company has 68 active competitors, including 23 funded and 4 that have exited. Its top competitors include companies like Organogenesis, Acera Surgical and GeniPhys.
Company Details
Provider of protein-based biomaterials for tissue engineering and regenerative medicine. The company offers genetically engineer protein-based materials that can mimic the naturally found elastin found in extracellular. The company's proprietary protein biomatrices known as Fractomers contain bio-active sequences that are thermo-responsive.
- Website
- insomabio.com
- Email ID
- *****@insomabio.com
Key Metrics
Founded Year
2018
Location
Durham, United States
Stage
Seed
Total Funding
$4.77M in 12 rounds
Latest Funding Round
Investors
Ranked
22nd among 68 active competitors
Employee Count
13 as on May 31, 2026
Similar Companies
Legal entities associated with inSoma Bio
inSoma Bio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
inSoma Bio, Inc. CIN: 832616729 , United States, Active | - | 8 (As on Dec 31, 2024) | - |
Sign up to download inSoma Bio's company profile
inSoma Bio's funding and investors
inSoma Bio has raised a total funding of $4.77M over 12 rounds. Its first funding round was on Sep 11, 2019. Its latest funding round was a Grant (prize money) round on Nov 28, 2025 for $*****. 1 investor participated in its latest round. inSoma Bio has 6 institutional investors.
Here is the list of recent funding rounds of inSoma Bio:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 28, 2025 | 9139742 | Grant (prize money) | 7963314 | 9646720 | 9901353 | 4206384 |
Sep 24, 2025 | 4788565 | Seed | 5426987 | 5802446 | 3562678 | 6417009 |
Jul 24, 2025 | 6009865 | Grant (prize money) | 4099536 | 8793279 | 8912099 |
View details of inSoma Bio's funding rounds and investors
inSoma Bio's founders and board of directors
Founder? Claim ProfileThe founders of inSoma Bio are Ashutosh Chilkoti, Stefan Roberts and Scott Hollenbeck. Stefan Roberts is the CEO of inSoma Bio.
Here are the details of inSoma Bio's key team members:
- Ashutosh Chilkoti: Co-Founder & Chairman of inSoma Bio. Contact Info: 1 email address
- Stefan Roberts: Co-Founder & CEO of inSoma Bio. Contact Info: 1 email address
- Scott Hollenbeck: Co-Founder of inSoma Bio. Contact Info: 1 email address
View details of inSoma Bio's Founder profiles and Board Members
inSoma Bio's employee count trend
inSoma Bio has 13 employees as of May 26. Here is inSoma Bio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
inSoma Bio's Competitors and alternates
Top competitors of inSoma Bio include Organogenesis, Acera Surgical and GeniPhys. Here is the list of Top 10 competitors of inSoma Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Organogenesis 1985, Canton (United States), Public | Regenerative tissue innovations for advanced wound care and surgical solutions | $30M | 59/100 | |
2nd | Acera Surgical 2013, St. Louis (United States), Acquired | Provider of synthetic electrospun scaffolds for regenerative medical applications | $6.32M | 57/100 | |
3rd | GeniPhys 2014, Zionsville (United States), Series A | Developer of collagen polymers for tissue regeneration | $13.5M | 53/100 | |
4th | BioTissue 2001, Miami (United States), Series C | Developer of regenerative biologic therapies for eye care | $110M | 52/100 | |
5th | RenovoDerm 2016, Columbus (United States), Seed | Developer of nanofiber-based wound care devices | $775K | 46/100 | |
6th | BioLab Sciences 2018, Scottsdale (United States), Unfunded | Developer of regenerative therapies for wound healing | - | - | 45/100 |
7th | Developer of patch system for wound healing | $52.4M | 44/100 | ||
8th | CLYRA Medical Technologies 2012, Westminster (United States), Seed | Developer of a regenerative technology for wound care | $50K | - | 44/100 |
9th | Polaroid Therapeutics 2022, Schlieren (Switzerland), Unfunded | Developer of antimicrobial solutions for wound healing | - | - | 42/100 |
10th | Regenesis 1996, Scottsdale (United States), Series C | Provider of at-home non-drug pain relief solutions for patients | $13.3M | 41/100 | |
22nd | inSoma Bio 2018, Durham (United States), Seed | Provider of protein-based biomaterials for tissue engineering and regenerative medicine | $4.77M | 33/100 |
Looking for more details on inSoma Bio's competitors? Click here to see the top ones
inSoma Bio's Investments and acquisitions
inSoma Bio has made no investments or acquisitions yet.
Reports related to inSoma Bio
Here is the latest report on inSoma Bio's sector:
Are you a Founder ?
FAQs about inSoma Bio
Explore our recently published companies
- Djalext - United Kingdom based, Unfunded company
- Diyhero - United Kingdom based, Unfunded company
- Dixonpurefill - United Kingdom based, Unfunded company
- Divinehealth - United Kingdom based, Unfunded company
- Divinedecorandmaintenance - United Kingdom based, Unfunded company
- Dissfitclub - United Kingdom based, Unfunded company